Goldman Sachs has identified several pharmaceutical stocks with significant upside potential, recommending those that could see price increases of up to 28 percent. These stocks are expected to perform well based on strong growth prospects, upcoming product launches,...
A leading pharmaceutical company has merged with Cohance Lifesciences to create India’s largest Contract Development and Manufacturing Organization (CDMO). This strategic merger is set to enhance their capabilities, expand market reach, and position the combined...
The shares of leading global pharmaceutical gained up to 12 percent after the company’s net profit and revenue stretched by 76 percent and 40 percent YoY, respectively in Q3FY25. Price movement With a market capitalization of Rs 29,156.60 crore, the shares of Suven...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
